Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Barr Pharmaceuticals
Barr's formal tender offer period for Pliva officially closes
November 7th, 2006
Barr Pharmaceuticals, Inc., (BRL) announced that the formal tender offer period for the offer by Barr's European subsidiary to purchase 100% of the shares of Pliva d.d., based in Zagreb, Croatia, has officially ended. The offer period for shareholders to tender their shares ended on October 11, 2006 at midnight Croatian time. Because Croatian law permits shareholders to mail in their acceptance forms, the company expects to receive from the Central Depository Agency ("CDA") the final results of the tender process on October 19, 2006. Under the terms of Barr's formal $2.5 billion cash tender offer, Pliva shareholders who tender their shares will receive HRK 820 per share...
Source: Drug Law Weekly (2006-11-07)
|
